Initial Myeloid Cell Status Is Associated with Clinical Outcomes of Renal Cell Carcinoma

The therapeutic outcome of immune checkpoint inhibition (ICI) can be improved through combination treatments with ICI therapy. Myeloid-derived suppressor cells (MDSCs) strongly suppress tumor immunity. MDSCs are a heterogeneous cell population, originating from the unusual differentiation of neutrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabrina, Saima, Takeda, Yuji, Kato, Tomoyuki, Naito, Sei, Ito, Hiromi, Takai, Yuki, Ushijima, Masaki, Narisawa, Takafumi, Kanno, Hidenori, Sakurai, Toshihiko, Saitoh, Shinichi, Araki, Akemi, Tsuchiya, Norihiko, Asao, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216014/
https://www.ncbi.nlm.nih.gov/pubmed/37238964
http://dx.doi.org/10.3390/biomedicines11051296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216014/
https://www.ncbi.nlm.nih.gov/pubmed/37238964
http://dx.doi.org/10.3390/biomedicines11051296

Ejemplares similares